| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/11/2008 | US7342016 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin |
| 03/11/2008 | US7342004 Superoxide dismutase inhibitors |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341994 to structurally mimic GD3, which are known as tumor associated antigens found in tumors such as melanoma; vaccine; i.e., a carcinostatic effect and an inhibitory effect for cancerous metastasis |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341870 Dendritic cell line |
| 03/11/2008 | US7341866 Gene expression patterns; diagnosis, therapy disease |
| 03/11/2008 | US7341749 Administering mixture of flavopereirine and alstonine for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia) |
| 03/11/2008 | US7341739 Small particle liposome aerosols for delivery of anti-cancer drugs |
| 03/11/2008 | US7341733 Pertussis toxin and analogs exhibit an adenosine-5* diphosphate-ribosyltransferase activity, useful in promoting prophylactic and/or therapeutic responses against another target antigen in a mammal patient |
| 03/11/2008 | US7341730 Inhibitors of angiogenesis and tumor growth |
| 03/11/2008 | US7341724 Apoptosis of rectum and prostate gland cancer |
| 03/11/2008 | US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide |
| 03/11/2008 | US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 03/11/2008 | US7341716 Solidifying mass in an ionic fluid- containing bodily cavity using polymer comprising 2-cyanoacrylate monomer |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2195425C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 03/06/2008 | WO2008027988A2 Methods of treating estrogen-responsive conditions by orphan nuclear receptor activation |
| 03/06/2008 | WO2008027839A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 03/06/2008 | WO2008027584A2 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase |
| 03/06/2008 | WO2008027542A2 5-substituted isoindoline compounds |
| 03/06/2008 | WO2008027523A2 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 03/06/2008 | WO2008027445A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 03/06/2008 | WO2008027055A1 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| 03/06/2008 | WO2008027013A2 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer |
| 03/06/2008 | WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient |
| 03/06/2008 | WO2008026769A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 03/06/2008 | WO2008026768A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | WO2008026748A1 Antitumor agent for undifferentiated gastric cancer |
| 03/06/2008 | WO2008026729A1 Therapeutic agent for pigmented villonodular synovitis or giant cell tumor of tendon sheath or bone |
| 03/06/2008 | WO2008026644A1 Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same |
| 03/06/2008 | WO2008026603A1 Anti-tumor agent |
| 03/06/2008 | WO2008026577A1 Method for producing phenoxypyridine derivative |
| 03/06/2008 | WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT |
| 03/06/2008 | WO2008026300A1 Neem seed-derived therapeutic agent for malignant tumor |
| 03/06/2008 | WO2008026149A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 03/06/2008 | WO2008026125A2 Anti cancer use of caffeic acid and derivatives |
| 03/06/2008 | WO2008026040A2 68ga-labeled peptide-based radiopharmaceuticals |
| 03/06/2008 | WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas |
| 03/06/2008 | WO2008025947A1 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
| 03/06/2008 | WO2008025848A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 03/06/2008 | WO2008025821A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025556A1 Sulphoximides as protein kinase inhibitors |
| 03/06/2008 | WO2008025540A1 Heterocyclic fxr binding compounds |
| 03/06/2008 | WO2008025526A1 Indole derivatives, their manufacture and use as pharmaceutical agents |
| 03/06/2008 | WO2008025509A1 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system |
| 03/06/2008 | WO2008025099A1 Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
| 03/06/2008 | WO2008025095A1 Method of eliciting or inducing an immune response |
| 03/06/2008 | WO2008025074A1 Method for reducing incidence or rate of development of skin cancers and related conditions |
| 03/06/2008 | WO2008025073A1 Method of modulation of expression of epidermal growth factor receptor (egfr) involving mirna |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | WO2008008549A3 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |
| 03/06/2008 | WO2008008432A3 Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods |
| 03/06/2008 | WO2008007122A3 Combinations of pyrazole derivatives for the inhibition of cdks and gsk's |
| 03/06/2008 | WO2008006884A3 Mtki quinazoline derivatives |
| 03/06/2008 | WO2008005956A3 Pyrrolotriazine kinase inhibitors |
| 03/06/2008 | WO2008003855A3 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 03/06/2008 | WO2007147518A3 Use of ppd for the adjuvantation of a nucleic acid vaccine |
| 03/06/2008 | WO2007146813A3 Pyridinone analogs as cell proliferation inhibitors |
| 03/06/2008 | WO2007143506A3 Substituted benzimidazole thiophene benzyl ether compounds |
| 03/06/2008 | WO2007141283A3 Salts and crystalline salt forms of an 2-indolinone derivative |
| 03/06/2008 | WO2007137000A3 Combination cancer chemotherapy |
| 03/06/2008 | WO2007133622A3 Selective inhibitors of rock protein kinase and uses thereof |
| 03/06/2008 | WO2007131736A3 Use of 4, 17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| 03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
| 03/06/2008 | WO2007124369A3 Method of inhibiting c kit kinase |
| 03/06/2008 | WO2007109609A3 Method for inhibiting angiogenesis |
| 03/06/2008 | WO2007093373A3 Branched multimeric peptides for tumor diagnosis and therapy |
| 03/06/2008 | US20080058519 Quinazoline ditosylate salt compounds |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058432 Measuring expression levels in a sample of tumor genes from the group consisting of those encoding mRNA corresponding to SEQ ID Nos: 7-28; analyzing the geneexpression to obtain gene expression profiles to predetermined cut-off levels indicative of recurrence; medical prognosis |
| 03/06/2008 | US20080058427 Cyclodextrin-based polymers for therapeutics delivery |
| 03/06/2008 | US20080058423 Melanin concentrating hormone antagonists |
| 03/06/2008 | US20080058422 Using alpha-ketoglutarate , mono- or divalent metal salts of alpha-ketoglutarate and/or ornithine of alpha-ketoglutarate; acting specifically on neoplastic cells with the simultaneous protective activity on the normal cells; synergic action with antineoplastic drugs and simultaneous protective activity |
| 03/06/2008 | US20080058411 Methods For Treating Resistant Or Refractory Tumors |
| 03/06/2008 | US20080058402 3-(1H-indol-2-yl)-1H-thieno[2,3-c]pyrazole-5-(N-phenoxycarboxamide); anticancer agents; protein kinase inhibitors |
| 03/06/2008 | US20080058386 1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-ylamine; inhibiting tubulin polymerization; anticarcinogenic; mitotic arrest of microtubule structure, neovascularization; angiogenesis inhibitor: atherosclerosis, rheumatoid arthritis or Crohn's disease, diabetic retinopathy, psoriasis |
| 03/06/2008 | US20080058364 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058358 Anticancer/antitumor agents; S-(4-([4-([(1R,2R)-2-Hydroxy-1-methylpropyl]amino)-5-(trifluoromethyl)-pyrimidin-2-yl]amino)phenyl)-S-methyl-N-[(trifluoromethyl)sulphonyl]-sulphimide for example |
| 03/06/2008 | US20080058355 Anticancer agents |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate |
| 03/06/2008 | US20080058347 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | US20080058346 Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof |
| 03/06/2008 | US20080058342 potent kinase insert domain-containing receptor (KDR) inhibitors with improved selectivity and pharmacokinetics; VEGF (vascular endothelial growth factor) inhibitors; cancer and rheumatoid arthritis; e.g. 7-(2-[4-(acetylmethyl)piperazin-1-yl]ethoxy)-6-methoxy-4-[(2-methyl-1H-indol-5-yl)oxy]quinazoline |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058338 Stable Solid Dosage Forms of Aminopterin |
| 03/06/2008 | US20080058337 Pyrrolotriazine kinase inhibitors |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/06/2008 | US20080058312 Modulators of hepatocyte growth factor/c-Met activity |
| 03/06/2008 | US20080058298 Blocking hedgehog protein transduction signal passageway using alkaloid steroid |
| 03/06/2008 | US20080058273 Brain disorders; antitumor agents |
| 03/06/2008 | US20080058268 Methods and Agents for the Treatment of Cancer |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |